Jayson Bedford
Stock Analyst at Raymond James
(3.81)
# 720
Out of 4,996 analysts
318
Total ratings
54.82%
Success rate
7.19%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $98.24 | +15.02% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $118.81 | +51.50% | 21 | Aug 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $108 → $102 | $80.20 | +27.18% | 28 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Strong Buy | $99 → $102 | $67.10 | +52.01% | 31 | Jul 31, 2025 | |
| BSX Boston Scientific | Maintains: Strong Buy | $121 → $124 | $98.18 | +26.30% | 26 | Jul 24, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $142 → $141 | $133.55 | +5.58% | 29 | Jul 18, 2025 | |
| PODD Insulet | Maintains: Outperform | $328 → $360 | $318.00 | +13.21% | 27 | May 27, 2025 | |
| MASI Masimo | Maintains: Outperform | $204 → $185 | $141.48 | +30.76% | 7 | May 7, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $162 → $164 | $179.71 | -8.74% | 23 | Apr 16, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $560 → $688 | $441.12 | +55.97% | 8 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $184.60 | +46.26% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $17.16 | -24.24% | 1 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $10.68 | -6.37% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $227 → $271 | $119.99 | +125.85% | 12 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $14.66 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $12.00 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $76.25 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.98 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $94.22 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $0.46 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $86 | $67.21 | +27.96% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.67 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $13.20 | - | 3 | Jan 2, 2018 |
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $98.24
Upside: +15.02%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $118.81
Upside: +51.50%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $80.20
Upside: +27.18%
DexCom
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $67.10
Upside: +52.01%
Boston Scientific
Jul 24, 2025
Maintains: Strong Buy
Price Target: $121 → $124
Current: $98.18
Upside: +26.30%
Abbott Laboratories
Jul 18, 2025
Maintains: Outperform
Price Target: $142 → $141
Current: $133.55
Upside: +5.58%
Insulet
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $318.00
Upside: +13.21%
Masimo
May 7, 2025
Maintains: Outperform
Price Target: $204 → $185
Current: $141.48
Upside: +30.76%
Johnson & Johnson
Apr 16, 2025
Maintains: Outperform
Price Target: $162 → $164
Current: $179.71
Upside: -8.74%
Intuitive Surgical
Jan 24, 2025
Maintains: Outperform
Price Target: $560 → $688
Current: $441.12
Upside: +55.97%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $184.60
Upside: +46.26%
Jul 1, 2024
Initiates: Outperform
Price Target: $13
Current: $17.16
Upside: -24.24%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $10.68
Upside: -6.37%
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $119.99
Upside: +125.85%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $14.66
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $12.00
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $76.25
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $21.98
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $94.22
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $0.46
Upside: -
Nov 5, 2020
Maintains: Outperform
Price Target: $75 → $86
Current: $67.21
Upside: +27.96%
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $1.67
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $13.20
Upside: -